Delivery Order SPE2DB22D2206-SPE2DB25FJB85
- Not listed
- This is a $14,508.62 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LAMICTAL 25 MG TABLET 100S, a prescription medication, with a performance period through September 7, 2023. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $3,318.84, is for the supply of 100 tablet bottles of the prescription drug Lamictal (Lamotrigine) 25 milligrams. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA that has a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,556,222,326 units of Lamictal 25 mg dispersible tablets. The total potential value of the order is $27,322.09, with a completion date of February 11, 2022. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and...
- This is a $12,083.19 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamictal 25mg tablets, a medication used to treat seizures and bipolar disorder. The contract has an ultimate completion date of May 21, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $22,501.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4562468216 LAMICTAL 25 MG DISPER TABLET 100S, with a period of performance through October 16, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,766.54 firm-fixed-price contract is for the delivery of Lamictal 150 mg tablets over a period ending on January 2, 2025. The contract is not a set-aside and was awarded on December 31, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
- This federal contract award is a delivery order valued at $21,224.00 issued to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of 100 mg Lamictal tablets. Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distributor. The contract has a ceiling value of $5,837.27 and runs through March 12, 2024. It is for the provision of Lamictal 150 mg tablets in 60-count packages. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a $2,587.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lamictal 200 mg tablets. The order is part of a larger $999,999,999 Indefinite Delivery Contract the DLA Troop Support Medical has with AmerisourceBergen for delivering a range of medical commodities to support military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lamictal 200 mg tablets. The $1,911.36 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJB85Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal 25 mg tablets (100-count units) valued at $19,868.41 on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, supplying the anticonvulsant and mood-stabilizing medication to support federal medical procurement needs. AmerisourceBergen Drug Corp serves as a critical vendor within DLA's pharmaceutical supply chain, leveraging its comprehensive IDC to deliver a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to military and veteran healthcare systems. The company's federal contract awards demonstrate consistent capability in meeting open competition requirements across multiple therapeutic domains. This delivery order for Lamictal tablets reflects the company's ongoing role in supporting the Defense Health Agency and other federal healthcare customers through the DLA Troop Support Medical contract vehicle, which enables flexible procurement of pharmaceutical commodities required for global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.9k | 7/25/25 |